Pharma Pulse 8/28/24: AI Regulation Is Coming, A Case for Payer Engagement/Participation in Clinical Research & more

A Case for Payer Engagement and Participation in Clinical Research

Collaboration can make commercialization processes efficient and effective.

Oral Iron Supplementation Remains Gold Standard in Anemia Care

Inflammatory conditions such as celiac disease can require care consideration and monitoring to manage iron deficiency.

AI Regulation Is Coming. Fortune 500 Companies Are Bracing for Impact.

Some 27% of Fortune 500 companies cite AI regulation as a risk in their annual reports.

Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine

Following FDA authorization and CDC recommendation, Rite Aid announced that scheduling is now available for eligible customers seeking the updated COVID-19 (2024-2025) vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. Appointments are available immediately.

Nicholas Saraceno on LinkedIn

Introducing the first session of #HDATraceability24- a state of implementation session featuring the FDA (Leigh Verbois, Abha Kundi). Certainly a robust Q&A regarding filing for a waiver, exception, or exemption (WEE), who would qualify, and the like. The FDA's RFI on "Implementing Interoperable Systems and Processes for Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act" has also been reopened till Sept. 12 of this year. Pharmaceutical Commerce Magazine HDA - Healthcare Distribution Alliance

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs